
Choisissez votre étiquette
affichée directement sur le flaconRapport de laboratoire
PDF- Testé
- Letrozol (Femara) 2.5mg × 100 Tabs
- Laboratoire
- Analiza Białek
- Date
- October 2026
- Résultat
- 2.72 mg per tablet (2.5 mg label)
- N° de commande
- Mot de passe
Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.
Letrozol (Femara)
PCT & AI
- Testé en laboratoire
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
En un coup d'œil
Letrozol (Femara) en chiffres
Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.
Article complet du lexiqueHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~3 days
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 2 to 4 days, we calculate with the middle.
Half-life
about2-4days
- Class
- Aromatase inhibitornon-steroidal, reversible
- Use
- Oral1-2x per week
- Sizes
- 2.5 mg2 sizes in the shop
What studies show
All 2 sources in the lexiconLetrozole vs tamoxifen in postmenopausal breast cancer (BIG 1-98) (opens in a new tab)
BIG 1-98 Collaborative Group, NEJM, 2005- over99 %Geisler et al., Journal of Clinical Oncology, 2002
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient Letrozol (Femara).
Tous les avisConnaissances
Tout sur Letrozol (Femara)
Informations détaillées bientôt disponibles.
Is letrozole approved?
Yes. In the USA letrozole has been approved as a prescription tablet since 25 July 1997 and ChEMBL lists phase 4 as the highest phase. The large studies concern breast cancer after menopause.
How much does letrozole lower estrogens?
In a study with 12 women who took both drugs one after the other, letrozole suppressed whole-body estrogen production by more than 99.1 percent and anastrozole by 97.3 percent. Estradiol in the blood fell by 87.8 percent with letrozole and estrone sulfate by 98.0 percent.
What did BIG 1-98 show?
Over 8,000 postmenopausal women with hormone-sensitive breast cancer received letrozole or tamoxifen. After five years an estimated 84.0 against 81.4 percent were free of recurrence and the risk of recurrence fell by 19 percent. In return skeletal and cardiac events as well as raised cholesterol were more common with letrozole.
What is known in PCOS?
In a study of 750 women with PCOS trying to conceive letrozole led to a live birth more often than clomiphene (27.5 against 19.1 percent) and to ovulation more often. Hot flushes were more common with clomiphene, fatigue and dizziness with letrozole.
What about bone and blood lipids?
Less estrogen means less protection for bone. In MA.17 5.8 percent on letrozole and 4.5 percent on placebo received a new osteoporosis diagnosis, the difference was not significant. In BIG 1-98 raised cholesterol was more common with letrozole.
How long does letrozole stay in the body?
The US label gives a terminal elimination half-life of about 2 days. According to the label a steady level is only reached after 2 to 6 weeks of daily use.
Comparatifs
Comment il se compare
Produits associés
Produits similaires
Clomid (Clomifen)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Tamoxifen (Nolvadex)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Testé en laboratoire
Aromasin (Exemestane)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Arimidex (Anastrozole)
Médicaments · Post-cycle & inhibiteurs de l'aromatase Post-cycle & inhibiteurs de l'aromatase
2 tailles
Letrozol (Femara)
